H. Lundbeck A/S
H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat maj… Read more
H. Lundbeck A/S (HLBBF) - Total Liabilities
Latest total liabilities as of December 2025: $29.04 Billion USD
Based on the latest financial reports, H. Lundbeck A/S (HLBBF) has total liabilities worth $29.04 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
H. Lundbeck A/S - Total Liabilities Trend (2004–2025)
This chart illustrates how H. Lundbeck A/S's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
H. Lundbeck A/S Competitors by Total Liabilities
The table below lists competitors of H. Lundbeck A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Anhui XDLK Microsystem Corp. Ltd. A
SHG:688582
|
China | CN¥65.40 Million |
|
Eurocommercial Properties N.V.
AS:ECMPA
|
Netherlands | €1.90 Billion |
|
HKBN Ltd
PINK:HKBNY
|
USA | $14.97 Billion |
|
Porto Seguro S.A
SA:PSSA3
|
Brazil | R$39.99 Billion |
|
Wuhan PS Information Tech
SHE:300184
|
China | CN¥2.58 Billion |
|
Clas Ohlson AB (publ)
ST:CLAS-B
|
Sweden | Skr4.58 Billion |
|
DIC Corporation
F:DPN
|
Germany | €789.67 Billion |
|
Northeast Securities Co Ltd
SHE:000686
|
China | CN¥89.63 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down H. Lundbeck A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how H. Lundbeck A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for H. Lundbeck A/S (2004–2025)
The table below shows the annual total liabilities of H. Lundbeck A/S from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $29.04 Billion | -9.14% |
| 2024-12-31 | $31.97 Billion | +108.08% |
| 2023-12-31 | $15.36 Billion | -7.86% |
| 2022-12-31 | $16.67 Billion | +1.83% |
| 2021-12-31 | $16.37 Billion | -14.07% |
| 2020-12-31 | $19.06 Billion | -10.13% |
| 2019-12-31 | $21.20 Billion | +142.04% |
| 2018-12-31 | $8.76 Billion | +15.64% |
| 2017-12-31 | $7.58 Billion | -27.97% |
| 2016-12-31 | $10.52 Billion | -16.14% |
| 2015-12-31 | $12.54 Billion | +3.54% |
| 2014-12-31 | $12.11 Billion | +19.11% |
| 2013-12-31 | $10.17 Billion | +21.55% |
| 2012-12-31 | $8.37 Billion | +7.82% |
| 2011-12-31 | $7.76 Billion | +12.71% |
| 2010-12-31 | $6.88 Billion | -17.31% |
| 2009-12-31 | $8.32 Billion | +65.99% |
| 2008-12-31 | $5.01 Billion | -2.46% |
| 2007-12-31 | $5.14 Billion | +5.65% |
| 2006-12-31 | $4.87 Billion | +17.64% |
| 2005-12-31 | $4.14 Billion | +12.71% |
| 2004-12-31 | $3.67 Billion | -- |